(Q43177533)

15 November 2017

Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine (English)

1 reference

15 November 2017

1 reference

1 reference

influenza B virus

1 reference

1

Donald F Smee

1 reference

15 November 2017

Miles K Wandersee

2

1 reference

15 November 2017

Min-Hui Wong

series ordinal

3

1 reference

15 November 2017

Kevin W Bailey

series ordinal

4

1 reference

15 November 2017

Robert W Sidwell

series ordinal

5

1 reference

15 November 2017

1 September 2004

1 reference

Antiviral Chemistry & Chemotherapy

15 November 2017

1 reference

15 November 2017

15

1 reference

15 November 2017

5

1 reference

15 November 2017

261-268

1 reference

Ribavirin small-particle-aerosol treatment of influenza B virus infection

15 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Zanamivir: a review of its use in influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Combinations of antiviral agents for treatment of influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Combination antiviral therapy for respiratory virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Antivirals for pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Viramidine, a prodrug of ribavirin, shows better liver-targeting properties and safety profiles than ribavirin in animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Disposition and metabolic profiles of [14C]viramidine and [14C]ribavirin in rat and monkey red blood cells and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Effect of selenazofurin on influenza A and B virus infections of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced Phlebovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

In vitro and in vivo Phlebovirus inhibition by ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Avian influenza: a new pandemic threat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Asian nations step up action to curb spread of avian influenza. Outbreak is spreading at an unprecendented speed, WHO says, and nowhere can be considered safe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

High protection of animals lethally infected with influenza virus by aprotinin-rimantadine combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500505

10.1177/095632020401500505

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference